Intranasal dexmedetomidine for sedation for pediatric computed tomography imaging
- PMID: 25748567
- DOI: 10.1016/j.jpeds.2015.01.036
Intranasal dexmedetomidine for sedation for pediatric computed tomography imaging
Abstract
This prospective observational pilot study evaluated the aerosolized intranasal route for dexmedetomidine as a safe, effective, and efficient option for infant and pediatric sedation for computed tomography imaging. The mean time to sedation was 13.4 minutes, with excellent image quality, no failed sedations, or significant adverse events.
Trial registration: Registered with ClinicalTrials.gov: NCT01900405.
Copyright © 2015 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical